Sushil Patel
Tracked across 1 events · 8 articles · First seen Jun 26, 2026 · Last active Jun 26, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Sushil Patel, as CEO of Replimune Group, expressed satisfaction with the United States — Food and Drug Administration's urgency in reviewing the RP1 BLA, highlighting the company's perspective on the regulatory process.
Jun 26, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Sushil Patel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard